Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999407 | Urologic Oncology: Seminars and Original Investigations | 2016 | 9 Pages |
Abstract
The degree of deterioration of renal function might predict the antitumor efficacy of sunitinib in patients with mRCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hironori M.D., Tsunenori M.D., Shoichi M.D., Ph.D., Toshio M.D., Kazunari M.D.,